Effectiveness and Safety of Semaglutide in Type 1 Diabetes: A Danish Nationwide Cohort Study (2018–2024)Research in context

Summary: Background: Semaglutide is not approved for glycemic management in type 1 diabetes (T1D) due to limited evidence and safety concerns. Nevertheless, its use is increasing. We investigated glycemic and safety outcomes of semaglutide in a nationwide cohort of individuals with T1D. Methods: Us...

Description complète

Détails bibliographiques

Auteurs principaux:	Puriya Daniel Würtz Yazdanfard, Vanja Kosjerina, Hannah Karin Wood-Kurland, Mikkel Porsborg Andersen, Eva Hommel, Thomas Fremming Dejgaard, Kirsten Nørgaard, Christian Torp-Pedersen, Kathrine Kold Sørensen
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2026-07-01
Collection:	The Lancet Regional Health. Europe
Sujets:	Diabetes Type 1 Semaglutide Danish Nationwide Diabetic ketoacidosis
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2666776226001286
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!